[3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone

C25H33F3N4O3 — CID 141241497

IUPAC[3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone
SMILESCCOC(C)(C)c1cc(C2CC(c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCOCC3)C2)[nH]n1
InChIInChI=1S/C25H33F3N4O3/c1-4-35-24(2,3)22-14-21(29-30-22)19-13-18(17-5-7-20(8-6-17)25(26,27)28)15-32(16-19)23(33)31-9-11-34-12-10-31/h5-8,14,18-19H,4,9-13,15-16H2,1-3H3,(H,29,30)
InChIKeyOPYNRXUDTPRFRH-UHFFFAOYSA-N
MW494.56 g/mol
LogP4.73
Rot. Bonds5

About [3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone

[3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone (PubChem CID 141241497) has the molecular formula C25H33F3N4O3 and a molecular weight of 494.56 g/mol. Its IUPAC name is [3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone.

Molecular Properties

Compound Name[3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone
PubChem CID141241497
Molecular FormulaC25H33F3N4O3
Molecular Weight494.56 g/mol
Exact Mass494.25
IUPAC Name[3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone
SMILESCCOC(C)(C)c1cc(C2CC(c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCOCC3)C2)[nH]n1
InChIInChI=1S/C25H33F3N4O3/c1-4-35-24(2,3)22-14-21(29-30-22)19-13-18(17-5-7-20(8-6-17)25(26,27)28)15-32(16-19)23(33)31-9-11-34-12-10-31/h5-8,14,18-19H,4,9-13,15-16H2,1-3H3,(H,29,30)
InChIKeyOPYNRXUDTPRFRH-UHFFFAOYSA-N
XLogP4.73
TPSA70.69 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms35
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500494.56
LogP ≤ 54.73
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze [3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone?
The IUPAC name of [3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone (CID 141241497) is [3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone.
What is the SMILES notation for [3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone?
The canonical SMILES for [3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone is CCOC(C)(C)c1cc(C2CC(c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCOCC3)C2)[nH]n1.
What is the InChIKey of [3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone?
The InChIKey is OPYNRXUDTPRFRH-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H33F3N4O3/c1-4-35-24(2,3)22-14-21(29-30-22)19-13-18(17-5-7-20(8-6-17)25(26,27)28)15-32(16-19)23(33)31-9-11-34-12-10-31/h5-8,14,18-19H,4,9-13,15-16H2,1-3H3,(H,29,30).
What are the key properties of [3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone?
[3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone has a molecular weight of 494.56 g/mol, XLogP of 4.73, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [3-[3-(2-ethoxypropan-2-yl)-1H-pyrazol-5-yl]-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]-morpholin-4-ylmethanone is sourced from PubChem (CID 141241497), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).